Terminated PHASE2 INTERVENTIONAL 2-arm NCT02627573

Trial of GVHD Prophylasxis With PTCy or Thymoglobulin in Unrelated SCT

Randomized Trial of GVHD Prophylasxis With Post-transplantation Cyclophocphomide (PTCy) or Thymoglobulin in Unrelated SCT Recepients With Chronic Myeloproliferative Neoplasms and Myelodisplatic Syndrome

Sponsor: St. Petersburg State Pavlov Medical University

Conditions Leukemia, Chronic Myeloid Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative Myelodysplastic Syndromes

Interventions Busulfan Cyclophosphamide Fludarabine monophosphate Mycophenolate mofetil Tacrolimus Thymoglobulin Unrelated allogeneic stem cell transplantation

Updated 9 times since 2017 Last updated: Apr 3, 2019 Started: Jul 31, 2015 Primary completion: Apr 3, 2019 Completion: Apr 3, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Poor recruitment

Other terminated trials from St. Petersburg State Pavlov Medical University

See all terminations from St. Petersburg State Pavlov Medical University

Listed as NCT02627573, this PHASE2 trial focuses on Leukemia, Chronic Myeloid and Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative and remains terminated or withdrawn. Sponsored by St. Petersburg State Pavlov Medical University, it has been updated 9 times since 2015, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Terminated PHASE2
Sep 2024 — Sep 2025 [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE2
May 2019 — Jan 2021 [monthly]

Terminated PHASE2

Status: Suspended → Terminated

▶ Show 4 earlier versions

Oct 2018 — May 2019 [monthly]

Suspended PHASE2

Status: Recruiting → Suspended
Jun 2018 — Oct 2018 [monthly]

Recruiting PHASE2
Sep 2017 — Jun 2018 [monthly]

Recruiting PHASE2
Jan 2017 — Sep 2017 [monthly]

Recruiting PHASE2

First recorded

Jul 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

St. Petersburg State Pavlov Medical University

Data source: St. Petersburg State Pavlov Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Saint Petersburg, Russia